A detailed history of Independence Bank Of Kentucky transactions in Novartis Ag stock. As of the latest transaction made, Independence Bank Of Kentucky holds 2,944 shares of NVS stock, worth $287,452. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,944
Previous 1,996 47.49%
Holding current value
$287,452
Previous $212,000 59.43%
% of portfolio
0.07%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$106.13 - $120.89 $100,611 - $114,603
948 Added 47.49%
2,944 $338,000
Q2 2024

Jul 25, 2024

BUY
$92.57 - $107.37 $3,054 - $3,543
33 Added 1.68%
1,996 $212,000
Q1 2024

Apr 16, 2024

BUY
$95.27 - $108.47 $32,963 - $37,530
346 Added 21.4%
1,963 $189,000
Q4 2023

Jan 23, 2024

BUY
$92.27 - $101.54 $130,746 - $143,882
1,417 Added 708.5%
1,617 $163,000
Q1 2023

Apr 06, 2023

SELL
$80.03 - $92.81 $35,213 - $40,836
-440 Reduced 68.75%
200 $18,000
Q4 2022

Jan 09, 2023

SELL
$75.55 - $92.52 $2,870 - $3,515
-38 Reduced 5.6%
640 $58,000
Q3 2022

Oct 06, 2022

SELL
$74.61 - $87.26 $6,714 - $7,853
-90 Reduced 11.72%
678 $52,000
Q1 2021

Apr 21, 2021

SELL
$83.5 - $98.47 $4,342 - $5,120
-52 Reduced 6.34%
768 $66,000
Q4 2020

Jan 22, 2021

SELL
$78.07 - $94.43 $3,903 - $4,721
-50 Reduced 5.75%
820 $77,000
Q3 2020

Oct 05, 2020

SELL
$82.14 - $91.0 $8,214 - $9,100
-100 Reduced 10.31%
870 $76,000
Q3 2019

Oct 21, 2019

BUY
$85.54 - $94.26 $44,480 - $49,015
520 Added 115.56%
970 $84,000
Q1 2019

Apr 29, 2019

BUY
$75.32 - $86.15 $11,297 - $12,922
150 Added 50.0%
450 $43,000
Q4 2017

Feb 08, 2018

BUY
$72.33 - $77.64 $21,699 - $23,292
300
300 $25,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $210B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Independence Bank Of Kentucky Portfolio

Follow Independence Bank Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independence Bank Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Independence Bank Of Kentucky with notifications on news.